Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Cholesterol-dependent lysosomal docking of mTORC1 mediated by TM6SF1.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Tissue-specific regulation of PNPLA3 promotes lipid remodeling in response to dietary and environmental challenges.
Journal: Journal of hepatology
Published: November 26, 2025
Tissue-specific regulation of PNPLA3 promotes lipid remodeling in response to dietary and temperature stress.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Genetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment.
Journal: Hepatology (Baltimore, Md.)
Published: November 21, 2025
PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis.
Journal: Journal of hepatology
Published: August 02, 2024
The ubiquitin E3 ligase BFAR promotes degradation of PNPLA3.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 31, 2024
Contribution of a genetic risk score to ethnic differences in fatty liver disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 29, 2022
Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 01, 2021
Molecular basis of cholesterol efflux via ABCG subfamily transporters.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 18, 2021
Last Updated: 09/26/2026